Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Gluzman, I.Y.; Francis, S.E.; Oksman, A.; Smith, C.E.; Duffin, K.L.; Goldberg, D.E.
    Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway (1994), J. Clin. Invest., 93, 1602-1608.
    View publication on PubMedView publication on EuropePMC

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.4.23.38 SC-50083 most selective inhibitor Plasmodium falciparum
3.4.23.39 Chloroquine-hemin complex
-
Plasmodium falciparum
3.4.23.39 pepstatin most selective inhibitor Plasmodium falciparum

Localization

EC Number Localization Comment Organism GeneOntology No. Textmining
3.4.23.38 vacuole
-
Plasmodium falciparum 5773
-
3.4.23.39 vacuole
-
Plasmodium falciparum 5773
-

Organism

EC Number Organism UniProt Comment Textmining
3.4.23.38 Plasmodium falciparum
-
-
-
3.4.23.39 Plasmodium falciparum
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.4.23.38 hemoglobin alpha-chain + H2O cleavage sites: Phe33-/-Leu34, Phe46-/-Asp47, Phe98-/-Lys99 Plasmodium falciparum ?
-
?
3.4.23.38 hemoglobin beta-chain + H2O cleavage sites: Leu31-/-Leu32, Phe41-/-Phe43, Ala129-/-Tyr130 Plasmodium falciparum ?
-
?
3.4.23.39 hemoglobin alpha-chain + H2O cleavage sites: Phe33-/-Leu34, Thr108-/-Leu109, Leu136-/-Thr137 Plasmodium falciparum ?
-
?
3.4.23.39 hemoglobin beta-chain + H2O cleavage site: Leu32-/-Val33 Plasmodium falciparum ?
-
?